Tuberculous Meningitis in Children: Reducing the Burden of Death and Disability

Julie Huynh1,2, Yara-Natalie Abo3,4, Karen du Preez5

  • 1Oxford University Clinical Research Unit, Centre for Tropical Medicine, Hospital for Tropical Diseases, Ho Chi Minh City 700000, Vietnam.

Insights

Tuberculous meningitis severely impacts children, causing high mortality and long-term neurodisability. Further research and improved diagnostics are crucial for better treatment outcomes in paediatric tuberculous meningitis.

Area of Science:

  • Pediatric infectious diseases
  • Neurology
  • Public health

Background:

  • Tuberculous meningitis (TBM) is a severe form of tuberculosis with high mortality and morbidity, especially in children.
  • Survivors often experience significant long-term neurodevelopmental deficits, posing a major global health challenge.
  • Current diagnostic and treatment strategies for pediatric TBM are insufficient, highlighting a critical gap in clinical management.

Purpose of the Study:

  • To review the current state of knowledge on pediatric tuberculous meningitis.
  • To identify clinical gaps and propose research questions for improving outcomes.
  • To emphasize the need for enhanced surveillance, diagnostics, and therapeutic strategies.

Main Methods:

  • This is a review article, synthesizing existing literature on pediatric tuberculous meningitis.
  • It focuses on identifying challenges in diagnosis, treatment, and long-term outcomes.
  • The review bridges clinical practice with future research directions.

Main Results:

  • Pediatric tuberculous meningitis remains a devastating disease with high rates of mortality and severe neurodisability.
  • There is an urgent need for advancements in rapid diagnostics, optimized anti-tuberculosis drug regimens, and host-directed therapies.
  • Further research is essential to understand and mitigate long-term functional and neurodevelopmental consequences.

Conclusions:

  • Paediatric tuberculous meningitis is a neglected but critical area requiring urgent attention.
  • Strengthening surveillance, developing rapid diagnostics, and optimizing treatment are paramount.
  • Addressing research gaps in long-term outcomes is vital for targeted interventions and improved patient care.

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
261
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
375
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
222
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
584
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
498
Vaccinations01:51

Vaccinations

Overview
45.6K